Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VitroGro ECM for Venous Leg Ulcers
NCT01982318Phase 3Withdrawn
- Sponsor
- Tissue Therapies
- Start
- Jan 2017
- Primary completion
- Jun 2018
01
Overview
A Phase 3 trial of VitroGro ECM in venous leg ulcer (VLU), sponsored by Tissue Therapies. Planned start Jan 2017; status: withdrawn.
02
Drugs
VitroGro ECM
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT01982318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982318.